Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
42.81
-0.25 (-0.58%)
: $42.86 +0.05 (+0.12%)
Products

FDA Says Will Not Object To Distribution Of Chantix With Nitrosamine Below Interim Acceptable Intake Limit

Published: 07/16/2021 20:26 GMT
Pfizer Inc. (PFE) - :fda Will Not Object to Distribution of Chantix (varenicline) With Nitrosamine Below the Interim Acceptable Intake Limit.
FDA - Will Not Object to Distribution of Varenicline Tablets With N-nitroso-varenicline Below Interim Acceptable Intake Limit of 185 Ng per Day.
FDA - Continues to Evaluate Data and May Update the Interim Acceptable Limit of Nitrosamine in Varenicline Tablets in the Future.
Further Company Coverage: Pfen ((reuters.
Briefs@thomsonreuters.
Com;)).